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ABSTRACT 
Introduction: To this day, COVID-19 still cause high mortality and morbidity in 
most cases. The severity of COVID-19 can be detected by simple tests such as 
complete blood counts which available in most health facilities. Through early 
detection of the estimated severity of COVID- 19, we may determine which patients 
need hospitalization or patients sufficient with self-isolation. Methods: We conduct 
an analytical, cross-sectional, retrospective study that analyzed the hematological 
parameters of 97 patients with positive rRT-PCR swabs in the period of March to 
August 2020. We compared hematologic parameters of COVID 19 patients with 
mild and moderate-severe. The receiver operating characteristic (ROC) curve, 
area under the curve (AUC), and Youden's index were created to determine the 
optimal cut-off value in predicting the degree of severity of COVID-19 patients. 
Results: Statistically significant differences (p <0.05) were found in the 
hematological parameters of neutrophils, NLR, PLR, MLR, ALC, lymphocyte, 
eosinophil, SGOT, SGPT, CRP, and calcium. SGPT parameter had the highest 
sensitivity value (94.4%), MLR had the highest specificity value (84.5%), and Hs-
CRP had the highest AUC value (AUC 0.789). Conclusion: Certain hematological 
parameters may assist in early detection of the severity of a COVID-19 patient. 
Our findings may be useful to determine whether the patient requires 
hospitalization or self-isolation. 
 
Keywords: COVID-19, Prognostic, Severity, Biomarkers, Hematologic Paramet 
 
ABSTRAK 
Pendahuluan: Sampai saat ini COVID-19 masih menimbulkan mortalitas dan 
morbiditas yang tinggi. Tingkat keparahan COVID-19 dapat dideteksi dengan 
pemeriksaan sederhana seperti darah lengkap yang tersedia di hampir semua 
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fasilitas kesehatan. Melalui deteksi dini perkiraan tingkat keparahan COVID-19, 
maka kita dapat memutuskan pasien yang membutuhkan rawat inap dan pasien 
yang cukup dengan isolasi mandiri. Metode: Penelitian analitik, cross-sectional, 
retrospektif yang menganalisa parameter hematologis pada 97 pasien dengan hasil 
swab rRT-PCR positif pada periode Maret hingga Agustus 2020. Parameter 
hematologis dibandingkan pada pasien COVID-19 dengan derajat keparahan ringan 
dan sedang-berat. Kurva receiver operating characteristic (ROC), area under the 
curve (AUC), dan Youden’s index dibuat untuk menentukan nilai cut-off optimal 
dalam memprediksi derajat keparahan pasien COVID-19. Hasil: Perbedaan 
bermakna (p < 0,05) didapati pada parameter hematologis neutrofil, NLR, PLR, 
MLR, ALC, limfosit, eosinofil, SGOT, SGPT, CRP, dan calcium. Parameter SGPT 
memiliki nilai sensitivitas tertinggi (94,4%), MLR memiliki nilai spesifitas yang 
paling tinggi (84,5%), dan Hs- CRP memiliki nilai AUC paling tinggi (AUC 0,789). 
Kesimpulan: Parameter hematologis tertentu dapat digunakan sebagai deteksi 
dini derajat keparahan pasien COVID-19. Hal tersebut sangat penting dalam 
menentukan apakah pasien tersebut memerlukan rawat inap atau dapat isolasi 
manndiri. 
 
Kata Kunci : COVID-19, Prognosis, Derajat Keparahan, Parameter Hematologis, 
Biomarker 
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In December 2019, an outbreak 
of acute respiratory infection occurs 
in the city of Wuhan, Hubei, China 
which identified as Severe Acute 
Respiratory Syndrome Coronavirus-2 
(SARS-CoV-2).1 The World Health 
Organization (WHO) publicize a new 
name for the disease called 
Coronavirus Disease 2019 (COVID-
19). In March 2020 WHO announced 
COVID-19 as a pandemic.2 In 
Indonesia, more than 600,000 cases 
were reported and more than 18,000 
deaths and this number is still 
growing. 
Based on the Clinical 
management of COVID-19 from 
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WHO, the severity of COVID-19 is 
classified into mild, moderate, severe, 
and critical. Mild disease include 
fever (83-99%), cough (59-82%), 
fatigue(44-70%), anorexia (40-84%), 
shortness of breath (31-40%), 
myalgia (11 -35%), and non-specific 
symptoms such as sore throat, nasal 
congestion, headache, diarrhea, 
nausea and vomiting. Anosmia and 
ageusia are reported to precede the 
onset of respiratory symptoms. 
Moderate disease were clinical 
symptoms of pneumonia, but no signs 
of severe pneumonia, including SpO2 
≥ 90% on room air. Severe disease are 
clinical signs of pneumonia 
accompanied by one or more 
symptoms of the following: 
respiratory rate>30 breaths/minute; 
severe respiratory distress; or SpO2 
<90% on room air.3 
The critical disease refers to 
ARDS (acute respiratory distress 
syndrome) symptoms with an onset of 
less than 1 week in patients with 
pneumonia or new cases or worsening 
of respiratory symptoms. Bilateral 
opacities, collapsed lungs or nodules 
were found on radiological images of 
the lungs or CT scan or ultrasound of 
the lungs. ARDS itself is divided into 
mild, moderate, and severe. Mild 
ARDS was marked as 200 mmHg 
<PaO2 / FiO2 a ≤ 300 mmHg (with 
PEEP or CPAP ≥ 5 cmH2O); 
moderate ARDS was marked as 100 
mmHg <PaO2 / FiO2 ≤ 200 mmHg 
(with PEEP ≥ 5 cmH2O); and severe 
ARDS characterized by PaO2 / FiO2 
≤ 100 mmHg (with PEEP ≥ 5 
cmH2O). Critical disease can also be 
found in patients with sepsis, septic 
shock, and multiple organ failure.3 
A study by Wang et al in China 
found hematological value could be 
utilized as parameter of severity in 
COVID-19, specifically the NLR 
value.4 Asghar et al confirmed a 
significant increase in NLR and PLR 
values in patients with severe 
COVID- 19 infection.5 Other studies 
have explained that hematological 
parameters such as leucocyte value 
(WBC), leucocyte count (differential 
count), liver function (SGOT / 
SGPT), CRP are one of the tools to 
predict the prognosis of COVID-19.6 
Elshazli et al emphasized 
hematological parameters are a 
reliable tool in predicting the 
morbidity rate of COVID-19 
infection so that periodic 
measurements are needed to monitor 
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the severity of the disease7. 
Nganjuk Regional General 
Hospital (RSUD) is one of the 
COVID-19 referral hospitals in East 
Java, specifically in Nganjuk 
Regency. The incidence of COVID-
19 infection in Nganjuk as of July has 
reached 90 confirmed COVID-19, 70 
cases of suspected COVID-19 and 
100 cases of probable COVID-19. 
Based on these data, this study aims 
to determine the role of hematological 




This research is an analytical, 
observational, and retrospective study 
at Nganjuk hospital. Samples in this 
study were all COVID-19 patients at 
Nganjuk Hospital who were 
diagnosed using rRT-PCR from 
March 2020 to September 2020, 
totaling 97 patients. A total of 58 of 
them were mild cases and 39 patients 
had COVID 19 moderate-severe 
cases. Classifications were divided 
using the WHO classification. Data 
from patients and laboratory values 
were taken from medical record data. 
Data analysis was using the 
IBM SPSS version 23. The normality 
of data distribution was determined 
using the Kolmogorov Smirnov test. 
Parametric data were displayed in 
numbers and percentages. Parametric 
data with abnormal distribution were 
displayed using median and Q1-Q3. 
Odd ratios were used in presenting 
risk factors data for patients to fall in 
a condition of severe severity. We 
used Chi-square test to analyze 
categorical variables, independent T- 
test to analyze parametric variables 
that were normally distributed, and 
the Mann-Whitney U to analyze 
parametric variables with abnormal 
distribution. Parametric variables that 
were statistically significant were 
analyzed with the receiver operating 
characteristic (ROC) curve, area 
under the curve (AUC), and Youden's 
index (J) were used to determine the 
optimal cut-off value in predicting the 
severity of COVID-19. In this study, 
95% confidence interval (CI) was 




Table 1. showed the clinical 
characteristic of patients with 
COVID-19 infection with a total 
sample of 97 in which divided into 
two groups: moderate-severe group (n 
= 39) and mild group (n = 58). In the 
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moderate-severe group, the average 
age of the patients was 46 years with 
mostly male (64.1%). Whereas in the 
mild severity group, the majority were 
female (56.9%) with an average age 
of patients who were younger (40.5 
years) than the moderate-severe 
group. Fever were the most prevalent 
complaints in the moderate-severe 
group (79.5%) and mild group 
(55.2%). There are statistically 
significant differences between two 
groups on the parameters of age, 
gender, clinical symptoms of cough, 
and clinical symptoms of dyspnea (p 
<0.05). Subjects in the moderate-
severe group had clinical symptoms 
of fever, cough and dyspnea which 
were more common than those in the 
mild group. 
 
Table 1. Clinical Characteristic COVID-19 Patients 
 
Clinical characteristic 
Covid-19 degree of severity 
OR P value Moderate-Severe 
(n = 39) 
Mild (n = 58) 
Age (years) 46 (38 – 60) 40,5 (23,75 – 48)  0,002* 
Gender 
Male 25 (64,1%) 25 (43,1%) 
2,357 0,042* 
Female 14 (35,9%) 33 (56,9%) 
Fever 
Yes 31 (79,5%) 32 (55,2%) 
3,14 0,014* 
No 8 (20,5%) 26 (44,8%) 
Cough 
Yes 29 (74,4%) 28 (48,3%) 
3,11 0,011* 
No 10 (25,6%) 30 (51,7%) 
Dyspnea 
Yes 22 (56,4%) 16 (27,6%) 
3,397 0,004* 
No 17 (43,6%) 42 (72,4%) 
Mialgia 
Yes 2 (5,1%) 2 (3,4%) 
1,80 0,683 
No 37 (94,9%) 56 (96,6%) 
Gastrointestinal disturbance 
Yes 7 (17,9%) 7 (12,1%) 
1,59 0,419 
No 32 (82,1%) 51 (87,9%) 
Table 1. showed the laboratory description of COVID-19 patients. In this study, results of 
significant comparisons were found in neutrophils, lymphocytes, eosinophils, NLR, ALC, PLR, 
MLR, SGOT, SGPT, BUN, creatinine, calcium, and Hs-CRP. Neutrophil, NLR, PLR, MLR, SGOT, 
SGPT, BUN, Sc, and CRP values were higher in the moderate-severe severity group than in mild 
severity group. Lymphocyte, ALC, and calcium values were found to be lower in the moderate-
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Covid-19 Degree of Severity 
P value 
Mild Q1-Q3 Moderate-Severe Q1-Q3 
Hb (g/dl) 13,8 (n = 58) 12,7 – 15,05 13,6 (n = 39) 12,7 – 15,4 0,941 
Leukocyte 9.400 (n = 58) 7.145 -11.637,5 8.960 (n = 39) 6.730 – 12.620 0,607 
Neutrophil (%) 63,95 (n = 58) 56,57 – 70,72 73,9 (n = 39) 70,5 - 82,4 0,000* 
Lymphocyte 
(%) 
25,15 (n = 58) 20,75 – 33,47 17,4 (n = 39) 9,5 – 22,9 0,000* 
Monocyte (%) 6,75 (n = 58) 5,62 – 8,65 6,9 (n = 39) 5,2 – 8,9 0,777 
Eosinophil (%) 1,25 (n = 58) 0,55 – 2,25 0,25 (n = 39) 0 – 1,1 0,000* 
Basophil (%) 0,4 (n = 58) 0,2 – 0,7 0,35 (n = 39) 0,17 – 0,7 0,766 
Hematocrit 40,9 (n = 58) 37,45 – 44,62 41,6 (n = 39) 37,3 – 43,5 0,912 
MCV 82,8 (n = 58) 79,4 – 86,82 82,3 (n = 39) 78,1 – 85,8 0,373 
Trombocyte 278.500 (n = 58) 245.250 – 340.500 233.000 (n = 39) 173.000 – 413.000 0,167 
MPV 9 (n = 58) 6,94 – 10,225 7,3750 (n = 39) 6,6 – 10,02 0,317 
NLR 2,5075 (n = 58) 1,7 – 3,48 4,2356 (n = 39) 3,07 – 9,29 0,000* 
ALC 2.129,81 (n = 58) 1.555,88 – 3.148,31 1.230,88 (n = 39) 968,5 – 1.898,88 0,000* 
PLR 120,6831 (n = 58) 90,50 – 168,57 170,997 (n = 39) 108,69 – 253,55 0,012* 
MLR 0,2817 (n = 58) 0,20 – 0,37 0,4619 (n = 39) 0,267 – 0,704 0,001* 
SGOT 24,6 (n = 48) 18,8 – 40,8 47,1 (n = 36) 29,225 – 76,825 0,000* 
SGPT 27,1 (n = 48) 16,95 – 44,15 46,9 (n = 36) 32,525 – 67,1 0,001* 
De Ritis Rasio 0,93 (n = 48) 0,75 – 1,45 1,006 (n = 36) 0,65 – 1,50 0,849 
BUN 9 (n = 40) 7 – 12,75 13 (n = 34) 10 – 16 0,002* 
Creatinine 0,81 (n = 40) 0,72 – 0,99 0,96 (n = 35) 0,81 – 1,2 0,009* 
Sodium 136 (n = 36) 132 – 138,75 134 (n = 29) 129 – 137 0,107 
Potassium 3,7 (n = 35) 3,4 – 4,0 3,7 (n = 29) 3,4 – 3,9 0,828 
Calcium 1,17 (n = 35) 1,12 – 1,23 1,12 (n = 29) 1,04 – 1,16 0,004* 
Hs-CRP 1,845 (n = 24) 0,21 – 7,44 20,135 (n = 18) 4,7 – 89,03 0,001* 
* = Significant mann Whitney-U test (p < 0,05) 
Hb: Hemoglobin; MCV: Mean cell volume; MLR: Monocyte lymphocyte ratio; NLR: Neutrophils 
lymphocyte ratio; PLR: Platelet lymphocyte ratio; SGOT: Serum Glutamic Oxaloacetic 
Transaminase; SGPT: Serum Glutamic Pyruvic Transaminase; MPV: Mean platelet volume; ALC: 
Absolute lymphocyte count; Hs-CRP: High-sensitivity C-reactive protein; Na: Natrium; K: Kalium; 
Ca: Calcium 
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Figure 1. Receiver Operating Characteristic (ROC) curve was performed to evaluate the cut off 
value of the hematological parameters in determining degree of severity of COVID-19. (A) The 
diagnostic value of neutrophils, NLR, PLR, MLR in determining the degree of severity in patients 
with COVID-19. (B) Diagnostic value of lymphocytes, eosinophils, and ALC in determining the 
degree of severity in patients with COVID-19. (C) The diagnostic value of SGOT and SGPT in 
determining the degree of severity in patients with COVID-19.(D) The diagnostic value of Hs-CRP 
in determining the degree of severity in patients with COVID-19. (E) The diagnostic value of 
Calcium in determining the degree of severity in patients with COVID-19. 
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All parameters (neutrophils, 
NLR, PLR, MLR, lymphocytes, 
eosinophils, ALC, SGOT, SGPT, Hs-
CRP, and Ca) were analyzed by ROC 
and have a statistically significant p 
value (p <0.05). SGPT parameters 
(cut off ≥ 23.3; AUC 0.717; CI 0.608-
0.826) had the highest sensitivity 
value (94.4%) in predicting the 
occurrence of moderate-severe 
degrees of severity in patients with 
COVID-19. Meanwhile, MLR 
parameter (cut off ≥ 0.4351; AUC 
0.695; CI 0.583-0.806) had the 
highest specificity value (84.5%) in 
predicting the occurrence of 
moderate-severe severity in patients 
with COVID-19. The highest AUC 
value was found in the Hs-CRP 
parameter (cut off ≥ 3.08; AUC 
0.789; CI 0.643-0.936) with a 
sensitivity of 88.9% and a specificity 
of 62.5%. (Table 3) 
Table 3. Cut Off Value 
Parameter Cut off Sensitivity Spesificity AUC CI 95% P value 
Neutrophil (%) ≥ 70,05 79,5% 72,4% 0,787 0,693-0,881 ,000* 
NLR ≥ 3,547 69,2% 77,6% 0,776 0,680-0,872 ,000* 
PLR ≥ 169,1386 51,3% 75,9% 0,651 0,538-0,763 ,012* 
MLR ≥ 0,4351 53,8% 84,5% 0,695 0,583-0,806 ,001* 
Lymphocyte (%) ≤ 20,8 71,1% 75,9% 0,766 0,667- 0,865 0,000* 
Eosinophil (%) ≤ 0,5 65,8% 75,9% 0,756 0,659- 0,853 0,000* 
ALC ≤ 1837,875 73,7% 65,5% 0,735 0,632- 0,838 0,000* 
SGOT ≥ 28,10 80,6% 62,5% 0,745 0,640-0,850 0,000* 
SGPT ≥ 23,30 94,4% 45,8% 0,717 0,608-0,826 0,001* 
Hs-CRP ≥ 3,08 88,9% 62,5% 0,789 0,643-0,936 0,001* 
Ca ≤ 1,185 93,1% 45,7% 0,711 0,584-0,839 0,002* 
MLR: Monocyte lymphocyte ratio; NLR: Neutrophils lymphocyte ratio; PLR: Platelet lymphocyte 
ratio; SGOT: Serum Glutamic Oxaloacetic Transaminase; SGPT: Serum Glutamic Pyruvic 




Mortality and morbidity rates 
of COVID-19 patients are still 
relatively high and puts a lot of 
burden in the community. From a 
complete blood count, we may obtain 
inflammatory markers such as NLR, 
MLR, PLR, and ALC which might be 
able to predict the severity of 
COVID-19 patients. 
This study found male have 
risk factors for falling in a more 
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severe condition than female. This 
study is in line with previous studies 
that found the severity and mortality 
of men was higher than women.8 
This result is likely due to higher 
estrogen levels in women. Estrogen 
has an anti- inflammatory effect that 
inhibits the inflammatory response.9 
This study found older people are 
more likely to have a higher degree 
of severity. Other studies found old 
age may be a predominant risk factor 
for severity and morbidity in COVID-
19 patient.8 The number of neutrophil 
counts in the mild group were lower 
than moderate- severe group. This 
result is in accordance with several 
previous meta-analysis studies which 
found higher neutrophil count value 
was commonly found in the severe 
and critical groups of COVID-19 
patients and could be used as a 
predictor of the severity of COVID-
19.10,11 
Eosinophil count value in the 
mild group was significantly higher 
than that in the moderate-severe 
group (1,250 vs 0.250). A study in 
China stated that patients with 
COVID-19 which treated in isolation 
rooms were more likely to be 
transferred to the ICU compared to 
groups with normal eosinophil 
values.12 A study by Liu F. in China 
stated during the treatment period, 
the number of eosinophil counts 
increased earlier in mild COVID-19 
cases than in moderate-severe cases. 
Increasing in number of eosinophils 
during the treatment period is also in 
line with the improvement in 
radiological and virological 
laboratory.13 
This study found lymphocyte 
count in the mild group was 
significantly higher than in 
moderate-severe group. 
Lymphopenia is the most common 
hemotological abnormalities in 
COVID-19 patients, which is around 
35-85%.14–16 Jiang et al. evaluated 
the lymphocyte counts in 103 
patients and found that CD3 +, CD4 
+, and CD8 + cells and NK cells 
decreased significantly in COVID-19 
patients, specifically in severe and 
critical COVID-19 patients.17 
NLR, PLR, and MLR are 
biomarkers that are widely studied in 
COVID-19 patients. MLR, PLR, and 
MLR indicate the inflammatory 
status of patient and are also 
biomarkers that could predict the 
prognosis of COVID-19 patients.18,19 
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High NLR, PLR, and MLR were 
predictors of the occurrence of severe 
COVID-19.18,20,21 Previous studies 
also obtained similar results. NLR, 
PLR, and MLR were higher in 
COVID-19 patients who were 
admitted to the ICU. Lymphocytes 
are the target of the virus because the 
SARS- CoV-2 virus bind to the 
angiotensin converting enzyme 2 
(ACE-2) receptor found on 
lymphocytes.22,23 Our study found 
high NLR, PLR and MLR values 
could be used as predictors of severe 
COVID-19. 
Our study found low ALC 
value is a predictor of severe 
COVID-19. Another study in United 
States found lower ALC in patients 
admitted to the ICU compared to 
non-ICUs patients. This finding is 
supported by a study in Singapore in 
which lower ALC values were found 
in ICU patients.24 Research in India 
showed significantly lower ALC 
values in symptomatic COVID-19 
patients compared to asymptomatic 
patients.25 
COVID-19 infection causes 
damage to various organs including 
liver. This happens because 
coronavirus binds to ACE-2 receptors 
in hepatocytes and cholangiocytes.26 
Based on a meta-analysis study, there 
was an increase in liver enzymes with 
an increase in SGOT by 21% and 
SGPT by 30% in patients with mild 
symptoms and an increase in SGOT 
by 48% and SGPT 38% in severe 
cases.27 A significant increase in 
SGOT was found in Wuhan in 62% 
of ICU patients and 25% in non-ICU 
patients.28 Our study found SGOT 
and SGPT were predicting factors 
with a high sensitivity of 80.6% and 
94.4%, respectively. 
Our study found an increasing 
CRP value in the moderate-severe 
group compared to the mild-severity 
group. CRP has a high sensitivity, 
namely 88.9% with a cutoff of ≥ 
3.08. Increased value of CRP are a 
predictor for severity in patients with 
COVID-19.29 Increased level of CRP 
correlates with lung lesions and the 
severity of the disease. 30,31 
Our study found BUN and 
serum creatinine were significantly 
higher in the moderate-severe group. 
The interaction of the SARS-CoV-2 
virus and the ACE-2 receptor in the 
kidneys caused abnormal activation 
of the renin-angiotensin-aldosterone 
system (RAAS) which increased 
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water absorption in the renal tubules 
and increased urea reabsorption, 
which will increase BUN levels in the 
blood.32 This has been proven in 
6.7% of patients with SARS infection 
experiencing acute kidney failure 
(AKI), and 37% in COVID-19 
patients.32,33 
The results showed calcium 
has a sensitivity of 93.1% with a 
cutoff of ≤ 1.185. Our study showed 
a decrease in calcium levels in the 
moderate-severe group compared to 
the mild group. In vitro experiments 
and animal models shown SARS-
CoV-E gene encodes a small 
transmembrane protein with ion 
channel activity that is synthesized 
during infection and suggest that 
changes in calcium homeostasis 
within cells can increase the 
activation of the inflammatory 
pathway leading to increased levels of 
IL-1b, TNF, and IL-6, associated 
with pulmonary cell damage34 
 
LIMITATIONS 
Limitations in this study are the 
relatively small number of patients. 
Hematological parameter data taken 
are not dynamically followed until 
patients are discharged. Patients’ 
comorbid disease was not further 
evaluated .For further studies, it is 
recommended to investigate the 




The hematological parameters 
in COVID-19 may help us predict the 
severity of COVID 19 and determine 
the appropriate treatment for the 
patients. Numbers of COVID-19 
patients which relatively increased 
every day, makes it necessary for us to 
sort out patients who need 
hospitalization or self-isolation. 
Complete blood as a simple test may 
help us predict the severity of 
COVID-19 patients. Through this 
research, it is hoped by examining 
certain hematological parameters, we 
may determine the degree of severity 
of COVID-19 patients. 
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